Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: LM10
  • Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

1316695-35-8

1316695-35-8 structure
1316695-35-8 structure
  • Name: LM10
  • Chemical Name: 6-Fluoro-3-[(E)-2-(1H-tetrazol-5-yl)vinyl]-1H-indole
  • CAS Number: 1316695-35-8
  • Molecular Formula: C11H8FN5
  • Molecular Weight: 229.213
  • Catalog: Research Areas Cancer
  • Create Date: 2018-12-25 10:34:33
  • Modify Date: 2024-01-05 18:13:29
  • LM10 is a potent inhibitor of tryptophan 2,3-dioxygenase (TDO). Tryptophan 2,3-dioxygenase (TDO) is an unrelated hepatic enzyme that also degrades tryptophan along the kynurenine pathway. LM10 has the potential for the research of cancer diseases[1].

Name 6-Fluoro-3-[(E)-2-(1H-tetrazol-5-yl)vinyl]-1H-indole
Synonyms 1H-Indole, 6-fluoro-3-[(E)-2-(1H-tetrazol-5-yl)ethenyl]-
6-Fluoro-3-[(E)-2-(1H-tetrazol-5-yl)vinyl]-1H-indole
Description LM10 is a potent inhibitor of tryptophan 2,3-dioxygenase (TDO). Tryptophan 2,3-dioxygenase (TDO) is an unrelated hepatic enzyme that also degrades tryptophan along the kynurenine pathway. LM10 has the potential for the research of cancer diseases[1].
Related Catalog
Target

TDO[1]

In Vivo LM10 (160 mg/kg; p.o.) prevents the growth of TDO-expressing P815 tumor cells and promotes better rejection of control clone P815B cl1, which does not express TDO[1]. LM10 displays a good TDO inhibition (Ki = 5.6 μM) with a competitive inhibition profile[1]. LM10 does not inhibit IDO and has a high solubility and bioavailability without obvious signs of toxicity[1]. The plasma concentration of LM10 after oral administration of 160 mg/kg/day is between 20 and 40 μg/mL (87-175 μM), a concentration about 40 times above the IC50 measured in the cellular assay performed with the physiological concentration of plasma tryptophan[1]. Animal Model: DBA/2 mice (6-8 weeks)[1] Dosage: 160 mg/kg/day Administration: p.o. Result: Prevented the growth of TDO-expressing P815 tumor cells and promoted better rejection of control clone P815B cl1, which does not express TDO.
References

[1]. Pilotte L, et al. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc Natl Acad Sci U S A. 2012;109(7):2497-2502.

Density 1.6±0.1 g/cm3
Boiling Point 522.5±60.0 °C at 760 mmHg
Molecular Formula C11H8FN5
Molecular Weight 229.213
Flash Point 269.8±32.9 °C
Exact Mass 229.076370
PSA 70.25000
LogP 1.80
Vapour Pressure 0.0±1.4 mmHg at 25°C
Index of Refraction 1.829
Storage condition -20℃
Precursor  3

DownStream  0